Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies

OBJECTIVE: To define the clinicopathologic features and diagnostic utility associated with anti‐cytosolic 5′‐nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). METHODS: Anti‐NT5C1A antibody status was clinically tested between 2014 and 2019 in the Washingt...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Clin Transl Neurol
Main Authors: Ikenaga, Chiseko, Findlay, Andrew R., Goyal, Namita A., Robinson, Sarah, Cauchi, Jonathan, Hussain, Yessar, Wang, Leo H., Kershen, Joshua C., Beson, Brent A., Wallendorf, Michael, Bucelli, Robert C., Mozaffar, Tahseen, Pestronk, Alan, Weihl, Conrad C.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951108/
https://ncbi.nlm.nih.gov/pubmed/33556224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51294
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares